ANI Pharmaceuticals Reports Full Year and Fourth Quarter 2019 Results, Provides 2020 Guidance and Remains on Track to Submit Cortrophin® Gel sNDA to FDA in March 2020
Go back to ANI Pharmaceuticals Reports Full Year and Fourth Quarter 2019 Results, Provides 2020 Guidance and Remains on Track to Submit Cortrophin® Gel sNDA to FDA in March 2020| ANI PHARMACEUTICALS (NASDAQ: ANIP) | Delayed: 78.85 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $78.85 | 52 Week High | $70.92 | |||
| Open | $78.85 | 52 Week Low | $26.80 | |||
| Day High | $78.85 | P/E | N/A | |||
| Day Low | $78.85 | EPS | $-0.96 | |||
| Volume | 223 | |||||
